Picture of Hisamitsu Pharmaceutical Co logo

4530 — Hisamitsu Pharmaceutical Co News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedMid CapHigh Flyer

Table: Hisamitsu - 9-MTH group results

Jan 6 (Reuters)- 
             Hisamitsu Pharmaceutical Co Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   9 months ended      9 months ended       Year to 
                  Nov 30, 2025        Nov 30, 2024     Feb 28, 2026 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales              114.51              111.25                     
                   (+2.9 pct)          (+8.2 pct)                   
  Operating           12.61               13.22                     
                   (-4.6 pct)          (+8.0 pct)                   
  Recurring           16.63               16.47                     
                   (+1.0 pct)          (-1.0 pct)                   
  Net                 11.89               13.66                     
                   (-13.0 pct)         (+13.0 pct)                  
  EPS              165.77 yen          185.02 yen                   
  EPS Diluted      165.57 yen          184.76 yen                   
  Ann Div                               90.00 yen        60.00 yen  
  -Q2 div           60.00 yen           45.00 yen                   
  -Q4 div                               45.00 yen           NIL     
  
  NOTE - Hisamitsu Pharmaceutical Co Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4530.T

Recent news on Hisamitsu Pharmaceutical Co

See all news